Additionally, phosphorylated mTOR (p‐mTOR) levels did not change with β‐Lap treatment alone or in combination with CGA in any of the cancer cells, despite the reduction in p‐mTOR levels induced by the mTOR inhibitor rapamycin (Figure 5e–h; Supporting Information: Figure 4e,f). The gene discussed is MTOR; the disease is cancer.